AI Summary
This article discusses how adding a fusion of parts of two genes to engineered T cells can enhance their ability to divide rapidly, kill more tumor cells, and survive longer without causing them to behave like cancer cells. This strategy may help improve immunotherapy for cancer treatment by leveraging the characteristics of cancerous T cells.
Adding a fusion of parts of two genes helped engineered T cells divide faster, kill more tumor cells, and survive longer in mice without making the T cells behave like cancer cells.